Stock Roaring Upward Mid-Session: Seattle Genetics, Inc. (NASDAQ:SGEN)

As of writing, Seattle Genetics, Inc.'s RSI stands at 78.63. (NASDAQ:SGEN). Ubs Asset Mgmt Americas Inc reported 0% stake. The brokerage now has a hold rating on the biotechnology company's stock. The firm has "Hold" rating by Cowen & Co given on Thursday, July 27. About 5,116 shares traded. SunTrust Banks, Inc. reaffirmed a hold rating and set a $45.00 target price on shares of Seattle Genetics in a report on Wednesday, October 4th. Verizon Communications Inc. had 51 analyst reports since July 22, 2015 according to SRatingsIntel. Piper Jaffray has "Hold" rating and $4800 target. Cognios Capital Llc sold 4,936 shares as the company's stock declined 2.84% while stock markets rallied. (NASDAQ:SGEN) recently. President and CEO Clay B. Siegall let go of 18,832 shares at an average price of $53.79 on Monday the 11th. Seattle Genetics, Inc. (NASDAQ:SGEN) has risen 75.68% since October 11, 2016 and is uptrending. Current price levels see the company 11.61% off the 20-day simple moving average. The stock's market cap is $8.30 billion. Cann reaffirmed a "hold" rating on shares of Seattle Genetics in a report on Thursday, April 27th. The biotechnology company reported ($0.42) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.41) by $0.01. The business had revenue of $108.20 million for the quarter, compared to analyst estimates of $105.92 million. Seattle Genetics had a negative return on equity of 32.87% and a negative net margin of 47.38%. During the same quarter in the previous year, the firm earned ($0.15) earnings per share.

A number of key analysts, polled by FactSet, shared their views about the current stock momentum.

Molecular Templates, Inc. (:MTEM)'s stock has performed at 102.84%. "(SGEN) Given a $46.00 Price Target at Cantor Fitzgerald" was originally posted by TrueBlueTribune and is owned by of TrueBlueTribune. If you are viewing this article on another website, it was illegally copied and reposted in violation of USA & worldwide copyright and trademark laws. It is quantified by short-term traders as the average difference between a stock's daily high and daily low, then divided by the stock price. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 10,000 shares were sold by HIMES VAUGHN B, worth $625,922. The shares were sold at an average price of $54.54, for a total value of $545,400.00. The disclosure for this sale can be found here. Inc. now owns 245,073 shares of the biotechnology company's stock worth $13,236,000 after buying an additional 152,504 shares in the last quarter.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in SGEN.

Shares of Seattle Genetics, Inc. are presently 34.99% off the 52 week low. Jane Street Group LLC acquired a new position in shares of Seattle Genetics during the third quarter worth $485,000. The institutional investor held 20,000 shares of the major banks company at the end of 2017Q2, valued at $1.02M, up from 7,000 at the end of the previous reported quarter. First Manhattan Co. lifted its stake in shares of Seattle Genetics by 31.3% in the 2nd quarter. Insiders sold a total of 38,930 shares of company stock worth $2,522,849 over the last 90 days. Piper Jaffray maintained Seattle Genetics, Inc. Following the transaction, the insider now directly owns 646,858 shares in the company, valued at approximately $40,745,585.42. Knowing how to interpret the information is another skill investors may need to master before becoming fully immersed in the stock market. More interesting news about Seattle Genetics, Inc. The Firm is engaged in the development and sale of pharmaceutical products on its own behalf or in collaboration with others. (NASDAQ:SGEN) were released by: and their article: "Seattle Genetics: Good Time To Buy Based On Adcetris Label Expansion" published on September 15, 2017 as well as's news article titled: "Genmab and Seattle Genetics to Initiate New Study of Novel Antibody-Drug ..." with publication date: October 10, 2017.

Like this



12 October 2017
Company stock datas that defines today's share market: Cardinal Health, Inc. (CAH)
The stock of Cardinal Health Inc (NYSE:CAH) has "Outperform" rating given on Thursday, February 11 by RBC Capital Markets. It has underperformed by 21.65% the S&P500. ( CAH ) by 92.81% based on its latest 2017Q2 regulatory filing with the SEC.

12 October 2017
Horizon Pharma, Inc. (NASDAQ:HZNP) Valuation According To Analysts
Therefore 77% are positive. 07/14/2016 - Horizon Pharma , Inc. had its "buy" rating reiterated by analysts at Brean Capital. The company has experienced volume of 2,325,091 shares while on average the company has a capacity of trading 3.62M share.

12 October 2017
Knicks jerseys to be sponsored by Squarespace
And the irony of the Knicks signing a deal with Squarespace was not lost on some. "We're excited to have Squarespace as a part of our team".

12 October 2017
Top GOP campaign operative joins White House press team
Trump made the claim in the Oval Office during a meeting with Henry Kissinger, according to a pool report . But this doesn't stop Trump from repeating the falsehood.

12 October 2017
Indian forces martyr three Kashmiris in gun battle
The fighting started when soldiers searching for militants cordoned off a neighbourhood in the northern town of Hajin. Sources said that two militants also made an appearance at the funeral.

12 October 2017
Ally Financial Inc (ALLY) on Focus After Trading At 52-Week Highs
Shares repurchase programs are generally an indication that the company's board of directors believes its shares are undervalued. The value of the investment in (ALLY) went from $39,544,000 to $42,672,000 a change of $3,128,000 quarter over quarter.

12 October 2017
Does Abeona Therapeutics (NASDAQ:ABEO) Look Attractive Now? Citigroup Initiates Coverage
There are 83 institutional holders with active positions, accounting for 15.4 million shares in total. 27,036 are held by Cwm Llc. The stock of Abeona Therapeutics Inc (NASDAQ: ABEO ) has "Buy" rating given on Thursday, September 8 by Cantor Fitzgerald.

12 October 2017
Digital Realty Trust Inc (NYSE:DLR) Institutional Investor Sentiment Analysis
Among 39 analysts covering Whiting Petroleum Corporation ( NYSE:WLL ), 10 have Buy rating, 7 Sell and 22 Hold. Barclays Capital maintained it with "Equal-Weight" rating and $10 target in Thursday, February 18 report.

12 October 2017
Royal Caribbean International unveils Symphony of the Seas features
Back by popular demand, the brand's first Broadway musical at sea - " Hairspray " - will return on Symphony with a total refresh. The new process will leverage a combination of facial recognition, bar codes and beacons to make boarding fast and frictionless.

12 October 2017
Olly Murs confirmed for The Voice
While Olly's new co-stars, Tom and Jennifer shared their thoughts on the cheeky Essex lad joining the team. Olly Murs has been confirmed as the brand new coach coming soon to The Voice UK .